Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
Mitochondrial complex I deficiency is the most common respiratory chain defect in mitochondrial disease in children and currently there is no effective treatment. In this study, the authors show that succinate prodrugs can alleviate metabolic decompensation in Leigh syndrome patient fibroblasts.
Guardado en:
Autores principales: | Johannes K. Ehinger, Sarah Piel, Rhonan Ford, Michael Karlsson, Fredrik Sjövall, Eleonor Åsander Frostner, Saori Morota, Robert W. Taylor, Doug M. Turnbull, Clive Cornell, Steven J. Moss, Carsten Metzsch, Magnus J. Hansson, Hans Fliri, Eskil Elmér |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/065e786aabe24902981472f3415f76d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity
por: Alina M. Bețiu, et al.
Publicado: (2021) -
pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects
por: Eduardo Burgarelli Lages, et al.
Publicado: (2021) -
Structure-guided microbial targeting of antistaphylococcal prodrugs
por: Justin J Miller, et al.
Publicado: (2021) -
Hypoxia-activated prodrugs and redox-responsive nanocarriers
por: Zeng Y, et al.
Publicado: (2018) -
Correction: Structure-guided microbial targeting of antistaphylococcal prodrugs
por: Justin J Miller, et al.
Publicado: (2021)